Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261209 · ClinicalTrials.gov registry record · Phase 1
Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand
A Phase 1 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00261209 is a Phase 1 study that has completed, run by Stony Brook University. The registered enrollment target is 3 participants.
The verdict
NCT00261209, a Phase 1 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to dissolve flexor tendon adhesions associated with failed tendon repair surgery.
Interventions
- DRUG Collagenase
- DRUG Collagenase injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00261209
The ClinicalTrials.gov registry entry for NCT00261209 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Collagenase is the first listed.
NCT00261209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00261209 about?
NCT00261209 is a clinical study titled "Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand". The purpose of this study is to dissolve flexor tendon adhesions associated with failed tendon repair surgery.
What is the current status of trial NCT00261209?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2005-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00261209?
The interventions under investigation include: Collagenase (DRUG), Collagenase injection (DRUG).
Who is sponsoring clinical trial NCT00261209?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.